Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol selectively modulates interleukin (IL)-1β and IL-6 production in toll-like receptor activated human peripheral blood monocytes
Sera Sermet, Jinpeng Li, Anthony Bach, et al.
Toxicology (2021) Vol. 464, pp. 153016-153016
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Toll-like receptor signalling as a cannabinoid target
Melody Cui Sun, Almudena Otálora-Alcaraz, Jack Prenderville, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116082-116082
Open Access | Times Cited: 11
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
Stefano De Martini, Alessandra Gemma, Marco Ferrari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3125-3125
Open Access | Times Cited: 17
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations
Abdel-ilah Aziz, Long Chi Nguyen, Loubna Oumeslakht, et al.
Cannabis and Cannabinoid Research (2022)
Closed Access | Times Cited: 24
Evaluation of the anti-inflammatory effects of selected cannabinoids and terpenes from Cannabis Sativa employing human primary leukocytes
Lance K. Blevins, Anthony Bach, Robert B. Crawford, et al.
Food and Chemical Toxicology (2022) Vol. 170, pp. 113458-113458
Closed Access | Times Cited: 21
Cannabidiol as a Promising Therapeutic Option in IC/BPS: In Vitro Evaluation of Its Protective Effects against Inflammation and Oxidative Stress
Tadeja Kuret, Mateja Erdani Kreft, Rok Romih, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5055-5055
Open Access | Times Cited: 13
Therapeutic Polymer-Based Cannabidiol Formulation: Tackling Neuroinflammation Associated with Ischemic Events in the Brain
Merari Tumin Chevalier, Mansoor Al-Waeel, Amir M. Alsharabasy, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1609-1624
Open Access | Times Cited: 4
Effects of a Cannabinoid-Based Phytocomplex (Pain ReliefTM) on Chronic Pain in Osteoarthritic Dogs
Ruggero Amato, Eleonora Pacifico, Daria Lotito, et al.
Animals (2025) Vol. 15, Iss. 1, pp. 101-101
Open Access
The role of cannabidiol in aging
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
The renoprotective effects of cannabidiol on lipopolysaccharide-induced systemic inflammation model of rats
İlter İlhan, Halil Aşçı, Özlem Özmen, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 3
The Therapeutic Potential of Cannabidiol in the Management of Temporomandibular Disorders and Orofacial Pain
Karolina Walczyńska-Dragon, Anna Kurek-Górecka, Jakub Fiegler-Rudol, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 328-328
Open Access
Research progress on febrile infection-related epilepsy syndrome
Li-Jia Zhang, Fangjing Li, Zucai Xu
New discovery. (2025), pp. 1-8
Closed Access
Aspartame and Ischemic Stroke: Unraveling the Molecular Link through Network Toxicology and Molecular Docking Analysis
Tianyu Zhang, Tao Wang, Kuangyang Yu, et al.
Research Square (Research Square) (2025)
Closed Access
The Incorporation of CBD into Biodegradable DL-Lactide/Glycolide Copolymers Creates a Persistent Antibacterial Environment: An In Vitro Study on Streptococcus mutans and Staphylococcus aureus
Ronit Vogt Sionov, Ahmad Siag, Emma Theresa Mersini, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 463-463
Open Access
Mode of action approach supports a lack of carcinogenic potential of six organic UV filters
Samuel M. Cohen, Alan R. Boobis, David Jacobson‐Kram, et al.
Critical Reviews in Toxicology (2025), pp. 1-37
Open Access
In Vitro Effects of Cannabidiol on Activated Immune–Inflammatory Pathways in Major Depressive Patients and Healthy Controls
Muanpetch Rachayon, Ketsupar Jirakran, Pimpayao Sodsai, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 405-405
Open Access | Times Cited: 15
Considerations for Cannabinoids in Perioperative Care by Anesthesiologists
Krzysztof Laudański, Justin Wain
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 558-558
Open Access | Times Cited: 14
Cannabidiol in the acute phase of febrile infection‐related epilepsy syndrome (FIRES)
Anna Fetta, Elisa Crotti, Elena Campostrini, et al.
Epilepsia Open (2023) Vol. 8, Iss. 2, pp. 685-691
Open Access | Times Cited: 7
Cannabidiol-Loaded Lipid-Stabilized Nanoparticles Alleviate Psoriasis Severity in Mice: A New Approach for Improved Topical Drug Delivery
Mark Zamansky, Yariv Doron, Valeria Feinshtein, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6907-6907
Open Access | Times Cited: 7
Cannabidiol and periodontal inflammatory disease: A critical assessment
P Jirásek, A Jusku, Vilı́m Šimánek, et al.
Biomedical Papers (2022) Vol. 166, Iss. 2, pp. 155-160
Open Access | Times Cited: 12
Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review
Alessandra Di Salvo, Elisabetta Chiaradia, Monica Sforna, et al.
Veterinary Research Communications (2024) Vol. 48, Iss. 5, pp. 2915-2941
Open Access | Times Cited: 2
The dual role of cannabidiol on monocyte-derived dendritic cell differentiation and maturation
Zsófia Pénzes, Shahrzad Alimohammadi, Dorottya Horváth, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Development of an in vitro peptide-stimulated T cell assay to evaluate immune effects by cannabinoid compounds
Olivia Cresswell, Karis Blankenship, Barbara L.F. Kaplan
International Immunopharmacology (2024) Vol. 129, pp. 111654-111654
Closed Access | Times Cited: 1
Examining the moderating role of cannabis use on the relationship between alcohol consumption and inflammation in individuals with alcohol use disorder
Erica N. Grodin, Kaitlin R. McManus, Lara A. Ray
Addiction Biology (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 1
Functional interleukin-4 releasing microparticles impact THP-1 differentiated macrophage phenotype
I‐Ning Lee, Jasmine Z. Stening, Felicity R. A. J. Rose, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 1
Effects of cannabidiol on activated immune-inflammatory pathways in major depressive patients and healthy controls
Muanpetch Rachayon, Ketsupar Jirakran, Pimpayao Sodsai, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top